拜瑞妥最新价格

(Rivaroxaban) is a highly selective, oral drug that directly inhibits factor xa. By inhibiting factor xa, the endogenous and exogenous pathways of the coagulation cascade can be interrupted, and the generation of thrombin and thrombosis can be inhibited. It obtained marketing approval in Canada and the European Union on September 15 and October 1, 2008 respectively. On July 1, 2011, the FDA approved the drug for the prevention of deep vein thrombosis in patients undergoing knee or hip replacement surgery. It was approved for sale by the State Food and Drug Administration in March 2009. Today we will take a closer look at the latest price of Xarelto.

Xarelto (rivaroxaban) was approved by the State Food and Drug Administration for marketing in China in 2009. In the same year, Xarelto was also included in the national medical insurance catalog, which relieved a certain burden on the treatment of many domestic patients.

According to Medical Companion Travel, Xarelto 10mgx28 tablets is about 170, 15mgx28 tablets is about 500$, and 20mgx28 tablets is about 500$. Since exchange rates fluctuate and prices are not fixed, please consult Medical Travel for specific prices. Patients in need can purchase Xarelto at major domestic pharmacies or obtain Xarelto (Xarelto) through domestic professional overseas medical service institutions (such as Medical Travel) to ensure that the drug is genuine.

Xarelto (rivaroxaban) has good efficacy mainly because Xarelto is a highly selective oral drug that directly inhibits factor Xa. By inhibiting factor Xarelto does not inhibit thrombin (activated factor II) and has no proven effect on platelets.

A dose-dependent inhibition of factor Xa activity by Xarelto has been observed in humans. Clinical studies have shown that Xarelto (rivaroxaban) can effectively prevent deep vein thrombosis after peri-hip fracture surgery. It has good safety and is worthy of clinical promotion.

Xarelto (rivaroxaban) is a highly selective, oral drug that directly inhibits factor Xa. Clinically indicated for the prevention of venous thrombosis (VTE) in adult patients undergoing elective hip or knee replacement surgery. It should be noted that patients who are allergic to Xarelto or any excipients in the tablets; patients with clinically significant active bleeding; patients with liver disease with coagulation abnormalities and clinically relevant bleeding risks; pregnant and lactating women are contraindicated.

The above is the price content of (Rivaroxaban), I hope it can help you!

Recommended related hot articles: /newsDetail/76578.html